Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.8K Buy
+100
New +$11.5K ﹤0.01% 225
2025
Q2
Sell
-1
Closed -$120 538
2025
Q1
$120 Hold
1
﹤0.01% 512
2024
Q4
$117 Hold
1
﹤0.01% 517
2024
Q3
$136 Buy
+1
New +$134 ﹤0.01% 506

Other funds holding XYL

West Branch Capital's XYL Position: Q2 2026 in Review

West Branch Capital opened a new position in Xylem (XYL) in Q2 2026: 100 shares worth $11.8K. The stake represents ﹤0.01% of the portfolio and ranks #225 among its holdings. This is a return to the name: West Branch Capital previously reported a position in XYL as recently as Q1 2025.

West Branch Capital first reported a position in XYL in Q3 2024 and has held it in 4 quarters since. 141 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • West Branch Capital held 100 shares of Xylem worth $11.8K as of Q2 2026.
  • Xylem was a new West Branch Capital position in Q2 2026.
  • Xylem made up ﹤0.01% of West Branch Capital's portfolio in Q2 2026, its #225 holding.
  • West Branch Capital first reported a position in Xylem in Q3 2024 and has held it in 4 quarters since.
  • 141 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on West Branch Capital's 13F filing for Q2 2026, filed 10 Jul 2026.